Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Bristol-Myers, Roche, working on possible blockbusters for melanoma, WSJ says
Yahoo/Fly on the Wall
Mon, 03/24/14 - 08:50 am
Tags:
Bristol-Myers Squibb, Roche, melanoma, AstraZeneca
Big pharma balks at investment in TB
Financial Times
Mon, 03/24/14 - 08:33 am
Tags:
tuberculosis, R&D, AstraZeneca, JNJ
AstraZeneca unveils direct-to-patient Nexium sales to fend off generic rivals
Fierce Pharma
Thu, 03/20/14 - 05:48 pm
Tags:
AstraZeneca, DTC, Nexium, generics
Nektar Rises on FDA Notification
Yahoo/Zacks.com
Thu, 03/20/14 - 09:07 am
Tags:
FDA, Nektar, AstraZeneca, Naloxegol, opioid-induced constipation
AstraZeneca Plc After The Patent Cliff
Motley Fool
Thu, 03/20/14 - 08:43 am
Tags:
patents, AstraZeneca, patent cliff
Rivals race to develop new biotech asthma drugs
Yahoo/Reuters
Tue, 03/18/14 - 08:59 am
Tags:
asthma, GSK, mepolizumab, Roche, AstraZeneca, Sanofi, Teva Pharmaceuticals
Big Pharma still betting on "messed up" Indian drugs market
Yahoo/Reuters
Wed, 03/12/14 - 09:03 am
Tags:
India, GSK, AstraZeneca, Abbott Labs
Ranbaxy scrambles for ingredients to make generic Nexium
Yahoo/Reuters
Tue, 03/11/14 - 08:42 am
Tags:
generics, Nexium, Ranbaxy, AstraZeneca
AstraZeneca Says Nexium Is ‘Still Safe’ With Ranbaxy Ingredient
Wall St Cheat Sheet
Mon, 03/10/14 - 08:15 am
Tags:
Nexium, Ranbaxy, recalls, AstraZeneca
Can Diabetes Treatments Replace Patent Losses At Eli Lilly & Co?
Motley Fool
Thu, 03/6/14 - 10:17 am
Tags:
Eli Lilly, diabetes, patents, dulaglutide, GLP-1 agonist, Novo Nordisk, AstraZeneca, GSK, JNJ
If You Can't Make Your Drug a Blockbuster, Sue Your Competitor
Motley Fool
Tue, 03/4/14 - 10:25 pm
Tags:
Vascepa, Amarin, GSK, AstraZeneca
Health-Care Deals Make Explosive Start to 2014
Motley Fool
Mon, 03/3/14 - 09:13 pm
Tags:
Actavis, Forest Labs, JNJ, AstraZeneca, Bristol-Myers Squibb, Aptalis, M&A
AstraZeneca announces FDA approval of Bydureon Pen
The Fly on the Wall
Mon, 03/3/14 - 10:05 am
Tags:
FDA, diabetes, AstraZeneca, Bydureon, Bydureon pen
Astrazeneca Pharma India surges on delisting proposal
Yahoo/Reuters
Mon, 03/3/14 - 08:34 am
Tags:
AstraZeneca Pharma India, India, AstraZeneca
Who loses most in Lilly vs. Novo diabetes study? AstraZeneca
Fierce Pharma
Wed, 02/26/14 - 07:02 pm
Tags:
Victoza, Novo Nordisk, Eli Lilly, dulaglutide, diabetes, Bydureon, AstraZeneca
Clock Is Ticking For AstraZeneca
Forbes
Tue, 02/25/14 - 03:57 pm
Tags:
AstraZeneca, dulaglutide, GSK, Eli Lilly, Bydureon, diabetes
5 Pharmas Spending the Most to Develop Drugs: Merck, AstraZeneca, Roche, Bristol, and Lilly
Motley Fool
Tue, 02/25/14 - 07:22 am
Tags:
Merck, AstraZeneca, Roche, Bristol-Myers Squibb, Eli Lilly, R&D, drug development
With Teva's Symbicort copy nearing EU launch, AstraZeneca preps for battle
Fierce Pharma
Mon, 02/24/14 - 05:11 pm
Tags:
Symbicort, generics, Europe, AstraZeneca, Teva Pharmaceuticals
2 FDA Decisions You Need to Watch Next Week
Motley Fool
Fri, 02/21/14 - 05:12 pm
Tags:
FDA, metreleptin, Bristol-Myers Squibb, lipodystrophy, AstraZeneca, hypogonadism, Endo Health Solutions, Aveed
Can AstraZeneca plc Make £5 Billion Profit?
Motley Fool
Thu, 02/20/14 - 08:21 am
Tags:
AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.